Catyalyst Pharmaceutical (CPRX) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.39 +0.03%
Revenue Growth %: +5.9%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +5.9%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q4 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
- Worthington Enterprises raises dividend 5%, adds board member
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
